• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » March 2007 – The CenterWatch Monthly : PDF
March 2007 – The CenterWatch Monthly : PDF

March 2007 – The CenterWatch Monthly : PDF

$79.00

Product Details

FDA Oversight Doesn't Cool Device Market

Post-marketing scrutiny of medical devices by regulators has been ratcheted up following safety questions about drug-coated stents and other medical devices. Contract research organizations (CROs) that have strong experience with post-marketing work and with smaller biotech startups have an advantage in the medical device market.

Should Prisoners Be Allowed to Volunteer for Research?

The use of prisoners as research subjects is one of the most controversial areas of human subjects research, and it has a long, complex history. The Institute of Medicine of the National Academies Report, "Ethical Considerations for Research Involving Prisoners," urges greater oversight and safeguards in human subjects research involving prisoners. It is important to understand the report's conclusions in their proper context, not as the last word in the discussion but as the latest chapter in an ongoing ethical debate that will likely continue for some time. Given the recent resurgence of discussion on prisoners as research subjects, the time is right to give the issue a thorough review.

Volterys Offers New Patient Recruitment Model in Europe

Volterys is a volunteer recruitment web site recently launched in France and Belgium. It represents a new patient recruitment model in Western Europe, one that circumvents some of the cultural barriers in Western Europe that prohibit recruiting patients for clinical trials over the Internet.

Eye On Hepatitis C

Hepatitis C, a liver inflammation caused by the hepatitis C virus (HCV), affects nearly 170 million people worldwide, making it the most common chronic blood-borne infection in developed countries. Currently, there is no approved vaccine to prevent hepatitis C.

Also in this issue:

  • Month in Review
  • TrialWatch
  • Opportunities Initiating
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing